LAWSUITS NEWS & LEGAL INFORMATION
Search Results for
Sort by date 131 pages found matching Glaxo- More Avandia Lawsuits Settled
Jun-2-10 Philadelphia, PA Reuters reported yesterday that GlaxoSmithKline has settled additional Avandia lawsuits . The lawsuits alleged that GlaxoSmithKline, the maker of Avandia, failed to adequately warn patients about the risk of serious side effects. A GlaxoSmithKline spokesperson announced the settlement on June 1, 2010, but did not give further detail... - The Faces Behind the Paxil Birth Defect Headlines
Feb-20-10 Philadelphia, PA Stories about Paxil side effects are always accompanied by headlines that contains words and numbers—but not necessarily faces. The people behind the headlines are too often overshadowed by the statistics. There is Meah Gibson, the little girl who was born with a hole in her heart in 2005. It was eventually corrected by surger... - Fixodent Denture Adhesive Linked to Nerve Damage
Jan-25-10 Charlotte, NC Fixodent denture adhesive has been linked to adverse health effects, largely due to the amount of zinc found within the product. This includes frequent complaints of nerve damage from longtime users of denture cream, like Johnny Howell. Howell, a 20-year user of both Fixodent and Poligrip, recently began losing feeling in his legs while... - Mothers Act Fuels Multibillion Dollar Industry - Part 3 of 3
Apr-14-09 PART ONE - PART TWO The prescribing of seven drugs, including two antipsychotics and five antidepressants, to treat OCD is a typical example of the profit-driven drugging that women snagged by the Mother's Act will face, but it's a far cry from the description Katherine wrote about regarding the comparatively minor treatment she received, when she st... - You May Not Want to Gamble on Requip, Because You Just Might…
Jan-27-09 Rochester, MN: It boggles the mind that a drug could foster the start of a compulsive Requip gambling habit. But that appears to be the case with Requip, a medication often prescribed to Parkinson's patients and those suffering from restless leg syndrome. As a result Requip compulsive gambling has proven an embarrassing, and costly adverse reaction. The... - Did Avandia Maker Attempt to Stifle Early Warnings?
Jan-25-09 Hagerstown, MD An investigation released November 19th, 2008 by the Canadian Broadcasting Corporation (CBC) revealed instances of mistreatment of two doctors who raised some of the earliest warnings with regard to Avandia and links to heart attack . The doctors, both based in the US, reported feeling intimidated after SmithKline Beecham, the forerunner... - The FDA Guerillas of Wonky DrugWonks - Part II
Aug-15-08 Continued from Aug-12-08 The tribe of Guerillas operating a Big Pharma public relations firm under cover of the Center for Public Integrity in Medicine may soon be on the path to extinction and the blogs on DrugWonks by the two out-of-control top bananas will likely be cause. Former FDA officials from the Bush Administration organized this industry fun... - Dangerous Asthma Drugs: Short-Term Relief, Long-Term Death
Jun-10-08 Washington, DC Take our dangerous asthma drug . Please. It will relieve your symptoms. Oh, but it could also worsen your asthma, which could kill you. But you'll die happy. Have a nice day. Give us a break. Are you as sick as the rest of us with the 'drugification' of America? They make drugs for everything, and more than half the time the drugs ar... - New Study Praising Avandia Called Insignificant
Apr-10-08 Los Angeles, CA When a drug is vilified as much as diabetes drug Avandia has for the risk of heart attack , one could understand the zeal with which a manufacturer approaches any piece of seemingly good news. This most recent carrot came in the form of a small study, which appears to suggest that Avandia can slow the progression of atherosclerosis in di... - Preemption - Bush Administration Backs Medtronic in Supreme Court - Part I
Jan-1-08 Washington, DC: Under the arguments made before the US Supreme Court on December 4, 2007, by Deputy Solicitor General Edwin Kneedler, on behalf of the Bush Administration, in support of the medical device maker Medtronic, American citizens injured by a defective device would not be allowed to sue the manufacturer of a product, ever. In a nutshell, the g... - World Experts Demand End to Child Drugging in the US - Part I
Oct-25-07 Washington, DC: On October 12, 2007, experts in the field of psychiatry and child development from all over the world arrived in Washington to attend the annual conference of the International Center for the Study of Psychiatry and Psychology. This year's conference focused on one specific goal - to end the mass-prescribing of psychiatric drugs to children... - Attorney Subpoenas J&J AstraZeneca and Lilly for Hidden Antipsychotic Data Part II
Sep-10-07 Washington, DC Attorney Jim Gottstein is the director of the Law Project for Psychiatric Rights, a public interest law firm that has mounted a campaign against forced psychiatric drugging all over the country. He represents mostly indigent clients through his non-profit organization and is not involved in the lawsuits filed against the atypical makers by p... - FDA now flooded with reports of Heart Failures linked to Avandia
Aug-15-07 Washington, DC The Food and Drug Administration (FDA) has been bombarded with reports of heart attacks, heart failure, and heart-related hospitalizations in diabetics taking Avandia since May 21, the day the New England Journal of Medicine published Dr. Steven Nissen's startling analysis of the drug on the Internet. "The Associated Press obtained t... - Avandia's heart attack risk: are any of the experts "clean"?
Aug-13-07 Los Angeles, CA The diabetes drug Avandia , made by GlaxoSmithKline, hit the news with a bang Jun 14, 2007, when the influential New England Journal of Medicine published a study by heart expert Dr. Steven E. Nissen showing that patients taking the drug had a 43% increase in heart attack risk. This worrying news caught the FDA, diabetics and doctors... - Avandia Drug Maker's Stock Rises: FDA "Dropped the Ball" says Congressman
Aug-7-07 Gaithersburg, MD The International Herald Tribune reports that shares of GlaxoSmithKline, the maker of Avandia , rose the most in two years last week, after a U.S. FDA panel recommended that Avandia be kept on the market. The FDA panel was organized by U.S. Rep. Henry Waxman (D-California), who stated he believes the FDA may not be adequately requir... - Avandia Allowed to Continue, Despite Risks
Jul-31-07 Gaithersburg, MD: Avandia , it seems, is back. In a remarkable turn of events, the diabetes drug that was vilified for cardiovascular risks only a few short months ago and made headlines around the world, was given a new lease on life by a federal drug advisory committee Monday. The vote to allow Avandia to remain on the market was described as 'overwh... - Avandia Warnings might have prevented a Death
Jul-27-07 Dallas, TX Neil Pender's father passed away five years ago from a heart attack and he is angry. "My father started taking Avandia shortly after it was approved in 1999 but we didn't hear about the dangers of this drug until June of this year," says Pender. "My father, Roy, wasn't aware that he was a diabetic, but he did have high blood pressure," say... - VA Patient Quits Avandia
Jul-18-07 Fall River, MA Steve G. was diagnosed with diabetes in the late 1990s and started a treatment program that involved several medicaitons. His health was under control until October, 2005 when his doctor at the VA hospital prescribed Avandia . About one month later, he started having breathing problems. "Then I had a lot of pressure in my chest so I wou... - Lawmakers Go After Thugs at FDA Over Avandia
Jun-11-07 Washington, DC: In one of the latest developments in the Avandia diabetes drug saga, on June 7, 2007, a bipartisan group of powerful lawmakers sent a letter to FDA asking Commissioner Andrew von Eschenbach for an explanation of the agency's policy on conflicts of interest regarding hiring employees directly from drug companies regulated by the FDA. At... - Fireworks on Capitol Hill: FDA on the Defensive, Avandia Warnings Toughened
Jun-7-07 Washington, DC In an obvious attempt to save face, the U.S. Food and Drug Administration (FDA) yesterday announced severely toughened black box warnings for Avandia , and Actos - two diabetes drugs strongly suspected of increasing the risk of heart attack. In front of a packed Congressional hearing yesterday called to investigate the long delays by reg...